A nested polymerase chain reaction assay (nPCR) was used to investigate the potential of
human parvovirus B19 DNA to persist in blood or bone marrow samples obtained either …

Routine monitoring of parvovirus B19 (B19V) the first 6 months posttransplantation was
performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates …

We report an adult liver transplant recipient with parvovirus B19 infection, presenting as
chronic transfusion-dependent anemia ensuing l month post-transplantation. Both serum …

Human parvovirus B19 can persist in immunocompromised patients and may produce
severe clinical illness. In this retrospective study the incidence of B19-associated infections …

Parvovirus B19V infection can be a serious infection for hematology patients with underlying
hemolysis or compromised erythropoiesis syndromes. Although case reports of B19V …

Parvovirus B19 is a common, ubiquitous human pathogen. It is a small, single-stranded
linear, nonenveloped DNA virus classified into three different genotypes (genotype 1, Au …

BACKGROUND: Many reports document the transmission of human parvovirus B19 (B19)
infection by clotting factor concentrates manufactured from large plasma pools …

Persistent parvovirus B19 (PVB) infection has been reported sporadically in
immunocompromised patients including hematopoietic stem cell and solid organ transplant …

Human parvovirus B19 (B19) infection has been known to cause chronic anemia, pure red
cell aplasia (PRCA), glomerulopathy, and allograft dysfunction in kidney transplant (KT) …

Background: Clinical manifestations of parvovirus B19 infection in immunocompromised
patients are mostly reported as acute or chronic hematologic disorders. More recently …